Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2017, Article ID 6198530, 10 pages
https://doi.org/10.1155/2017/6198530
Review Article

Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives

Department of Neurology and MS Comprehensive Care Center, Stony Brook University Medical Center, Stony Brook, NY 11794, USA

Correspondence should be addressed to Patricia K. Coyle; ude.enicidemkoorbynots@elyoc.aicirtap

Received 26 January 2017; Revised 13 April 2017; Accepted 20 April 2017; Published 19 July 2017

Academic Editor: Oscar Fernandez

Copyright © 2017 Patricia K. Coyle. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Patricia K. Coyle, “Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives,” Multiple Sclerosis International, vol. 2017, Article ID 6198530, 10 pages, 2017. https://doi.org/10.1155/2017/6198530.